CSL - Operating Expenses


CSL reported $5.7B in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Arca Biopharma USD 34.43M 326K Dec/2025
aTyr Pharma USD 85.61M 58.67M Dec/2025
Bio Path USD 488K 4.07M Sep/2025
Brainstorm Cell Therapeutics USD 2.24M 197K Dec/2025
Cara Therapeutics USD 5.94M 983K Sep/2025
CSL USD 5.7B 2.82B Dec/2025
Curis USD 9.02M 23.01M Dec/2025
Esperion Therapeutics USD 83.21M 14.06M Dec/2025
Immunic USD 23.33M 2.67M Dec/2025
Minerva Neurosciences USD 4.52M 155.46K Dec/2024
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
TherapeuticsMD USD 1.41M 50K Jun/2024